Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. Sieder

Efficacy and Safety of Once-Daily QVA149 Compared With the Free Combination of Once-Daily Tiotropium Plus Twice-Daily Formoterol in Patients With Moderate-To-Severe COPD (QUANTIFY): A Randomised, Non-Inferiority Study

Thorax

Pulmonary

Respiratory Medicine

2015

English

Secukinumab Is Superior to Fumaric Acid Esters in Treating Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to Systemic Treatments: Results From the Randomized Controlled PRIME Trial

British Journal of Dermatology

Dermatology

Medicine

2017

English

Related publications

A Comparison of the Efficacy and Safety of Once-Daily Fluticasone Furoate/Vilanterol With Twice-Daily Fluticasone Propionate/Salmeterol in Moderate to Very Severe COPD

European Respiratory Journal

English

Efficacy of a New Once-Daily Long-Acting Inhaled 2-Agonist Indacaterol Versus Twice-Daily Formoterol in COPD

English

Efficacy and Safety of Ciclesonide Once Daily and Fluticasone Propionate Twice Daily in Children With Asthma

Pulmonary Pharmacology and Therapeutics

English

Comparison of Once Daily Versus Twice Daily Olmesartan in Patients With Chronic Kidney Disease

International Journal of Nephrology and Renovascular Disease

Nephrology

2013

English

Fluticasone Furoate: Once-Daily Evening Treatment Versus Twice-Daily Treatment in Moderate Asthma

English

Once-Daily Fluticasone Furoate/Vilanterol Combination Versus Twice-Daily Budesonide/Formoterol Combination in the Treatment of Controlled Stable Asthma: A Randomized Crossover Trial

Journal of Asthma and Allergy

English

Trough to Peak Ratio of Once-Daily Lisinopril and Twice-Daily Captopril in Patients With Essential Hypertension

Journal of Human Hypertension

Internal Medicine

1998

English

P250 Effects of 12 Weeks of Once-Daily Tiotropium and Olodaterol Fixed-Dose Combination on Exercise Endurance in Patients With Copd

English

Once-Daily Netarsudil vs Twice-Daily Timolol in Patients With Elevated Intraocular Pressure, the Randomized Phase 3 ROCKET-4 Study

American Journal of Ophthalmology

Ophthalmology

2019

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by C. Sieder

Efficacy and Safety of Once-Daily QVA149 Compared With the Free Combination of Once-Daily Tiotropium Plus Twice-Daily Formoterol in Patients With Moderate-To-Severe COPD (QUANTIFY): A Randomised, Non-Inferiority Study

Secukinumab Is Superior to Fumaric Acid Esters in Treating Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to Systemic Treatments: Results From the Randomized Controlled PRIME Trial

Related publications

A Comparison of the Efficacy and Safety of Once-Daily Fluticasone Furoate/Vilanterol With Twice-Daily Fluticasone Propionate/Salmeterol in Moderate to Very Severe COPD

Efficacy of a New Once-Daily Long-Acting Inhaled 2-Agonist Indacaterol Versus Twice-Daily Formoterol in COPD

Efficacy and Safety of Ciclesonide Once Daily and Fluticasone Propionate Twice Daily in Children With Asthma

Comparison of Once Daily Versus Twice Daily Olmesartan in Patients With Chronic Kidney Disease

Fluticasone Furoate: Once-Daily Evening Treatment Versus Twice-Daily Treatment in Moderate Asthma

Once-Daily Fluticasone Furoate/Vilanterol Combination Versus Twice-Daily Budesonide/Formoterol Combination in the Treatment of Controlled Stable Asthma: A Randomized Crossover Trial

Trough to Peak Ratio of Once-Daily Lisinopril and Twice-Daily Captopril in Patients With Essential Hypertension

P250 Effects of 12 Weeks of Once-Daily Tiotropium and Olodaterol Fixed-Dose Combination on Exercise Endurance in Patients With Copd

Once-Daily Netarsudil vs Twice-Daily Timolol in Patients With Elevated Intraocular Pressure, the Randomized Phase 3 ROCKET-4 Study